Literature DB >> 24753762

Effect of flumazenil on sevoflurane requirements for minimum alveolar anesthetic concentration-awake and recovery status.

Peng Liang1, Cheng Zhou1, Kai-Yu Li2, Li-Juan Guo1, Bin Liu1, Jin Liu1.   

Abstract

OBJECTIVE: It is controversial that whether the GABA receptors contribute to the hypnotic action of volatile anesthetics. This study was to detect the effect of GABA receptors on the hypnotic action of volatile anesthetics by evaluation of the effect of intravenous flumazenil on sevoflurane minimum alveolar anesthetic concentration-awake (MAC-Awake) and emergence mental status.
METHODS: This study included two steps. Firstly, 49 healthy patients, aged 20-40 years scheduled for elective surgeries, were randomly assigned to two groups, a flumazenil group (n=24) and a saline group (n=25). The flumazenil group received 0.006 mg/Kg IV, and the control group received the same volume of saline 20 min before induction. The flumazenil group and the control group were compared with regard to MAC-Awake (anesthetic concentration achieving 50% probability of eye opening in response to a verbal command). We used the mask inhalation to measure the MAC-Awake by up-and-down method. The second steps, 60 patients undergoing lower abdomen surgeries were randomly divided into two groups, a experimental group (n=30) and a saline group (n=30). All patients were anesthetized with sevoflurane/sulfentanil. The experimental group received flumazenil at 0.006 mg/Kg IV, and the control group received the same volume of saline at the end of surgery. We recorded the time to awake and extubation. After extubation, the patients' recovery status was scored with the Mini-Mental state examination (MMSE) system in post anesthesia care unit (PACU).
RESULTS: The MAC-Awake was 0.65% in the control group and 0.82% in the flumazenil group (p=0.34). After extubation, the recovery time and time to extubation showed no difference between the flumazenil group and the saline group (p>0.05). But the 10 min and 15 min MMSE scores after extubation were better in the flumazenil group than those in the saline group (p<0.05). There was no difference for MMSE scores after 30 min between two groups.
CONCLUSION: We found that an IV flumazenil (0.006 mg/Kg) has no effect on sevoflurane MAC-Awake in humans. A single intravenous injection of flumazenil (0.006 mg/Kg) can partially reverse the hypnotic effect of sevoflurane/sulfentanil but do not contribute to reduction in the time to recovery and extubation.

Entities:  

Keywords:  Flumazenil; MAC-awake; sevoflurane; sulfentanil

Year:  2014        PMID: 24753762      PMCID: PMC3992407     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Influence of age on awakening concentrations of sevoflurane and isoflurane.

Authors:  T Katoh; Y Suguro; T Ikeda; T Kazama; K Ikeda
Journal:  Anesth Analg       Date:  1993-02       Impact factor: 5.108

2.  Flumazenil improves cognitive and neuromotor emergence and attenuates shivering after halothane-, enflurane- and isoflurane-based anesthesia.

Authors:  A A Weinbroum; E Geller
Journal:  Can J Anaesth       Date:  2001-11       Impact factor: 5.063

3.  Flumazenil expedites recovery from sevoflurane/remifentanil anaesthesia when administered to healthy unpremedicated patients.

Authors:  Agathi Karakosta; Beatrice Andreotti; Chara Chapsa; Aikaterini Pouliou; Emmanouil Anastasiou
Journal:  Eur J Anaesthesiol       Date:  2010-11       Impact factor: 4.330

4.  Effect of flumazenil on recovery from sevoflurane anesthesia in children premedicated with oral midazolam before undergoing herniorrhaphy with or without caudal analgesia.

Authors:  Hiromi Araki; Yoshihiro Fujiwara; Yasuhiro Shimada
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

5.  Effect of flumazenil on bispectral index monitoring in unpremedicated patients.

Authors:  Ashraf A Dahaba; Helmar Bornemann; Peter H Rehak; Geng Wang; Xin Min Wu; Helfried Metzler
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

6.  The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits.

Authors:  Koichi Nishikawa; Neil L Harrison
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

7.  MAC-awake of sevoflurane in children.

Authors:  Andrew J Davidson; Aaron Wong; Graham Knottenbelt; Suzette Sheppard; Susan Donath; Geoff Frawley
Journal:  Paediatr Anaesth       Date:  2008-08       Impact factor: 2.556

8.  Comparison of rapid and conventional inhalation inductions of halothane oxygen anesthesia in healthy men and women.

Authors:  J M Ruffle; M T Snider
Journal:  Anesthesiology       Date:  1987-10       Impact factor: 7.892

9.  Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient.

Authors:  G D Bell; G P Spickett; P A Reeve; A Morden; R F Logan
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

10.  Flumazenil reversal of sublingual triazolam: a randomized controlled clinical trial.

Authors:  Kazuo Hosaka; Douglass Jackson; Jacqueline E Pickrell; Masahiro Heima; Peter Milgrom
Journal:  J Am Dent Assoc       Date:  2009-05       Impact factor: 3.634

View more
  3 in total

1.  Flumazenil reduces respiratory complications during anesthesia emergence in children with preoperative upper respiratory tract infections.

Authors:  Ruiqiang Sun; Guolin Wang; Xuesong Gao; Shuzhen Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

2.  Reversal agents in anaesthesia and critical care.

Authors:  Nibedita Pani; Pradeep A Dongare; Rajeeb Kumar Mishra
Journal:  Indian J Anaesth       Date:  2015-10

3.  [The use of flumazenil for benzodiazepine associated respiratory depression in postanesthesia recovery: risks and outcomes].

Authors:  Troy G Seelhammer; Eric M DeGraff; Travis J Behrens; Justin C Robinson; Kristen L Selleck; Darrell R Schroeder; Juraj Sprung; Toby N Weingarten
Journal:  Braz J Anesthesiol       Date:  2018-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.